Lorelei Mucci, associate professor of epidemiology at Harvard T.H. Chan School of Public Health, is among the researchers participating in a new Stand Up To Cancer (SU2C) Dream Team focused on revolutionizing the treatment of multiple myeloma. Stand Up To Cancer announced on April 15, 2018 a $10 million award to the team, which will seek ways to detect the incurable blood cancer of plasma cells before the cells turn into a full-blown disease. The announcement was made at the 2018 Annual Meeting of the American Association for Cancer Research (AACR), SU2C’s scientific partner.
The target population for the survey includes people with first-degree relatives who have had multiple myeloma, and African-Americans, since African-Americans are three times more likely than whites to develop the precursor conditions, and tend to develop them at an earlier age.
Read a press release: Stand Up To Cancer Takes New Approach to Multiple Myeloma, Focusing on Precursor Conditions